Pharmaceutical

There are many good treatments now available for Mild Cognitive Impairment and early Alzheimer’s disease, but we know these treatments are most effective when diagnosis is made in the very early stages. ¬†Unfortunately, an estimated 60% of individuals are going undiagnosed until the disease is in later stages.

We are working with pharmaceutical companies in a number of ways, including sponsored screenings. We also offer you an opportunity to advertise directly to your market, in a targeted way never before available. If you are interested in partnering with us to find out how you can help ensure early screening is available to all seniors, please contact us.